You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 19, 2024

FLAGYL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Flagyl patents expire, and when can generic versions of Flagyl launch?

Flagyl is a drug marketed by Pfizer and Baxter Hlthcare and is included in five NDAs.

The generic ingredient in FLAGYL is metronidazole hydrochloride. There are eighteen drug master file entries for this compound. Additional details are available on the metronidazole hydrochloride profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for FLAGYL?
  • What are the global sales for FLAGYL?
  • What is Average Wholesale Price for FLAGYL?
Drug patent expirations by year for FLAGYL
Drug Prices for FLAGYL

See drug prices for FLAGYL

Drug Sales Revenue Trends for FLAGYL

See drug sales revenues for FLAGYL

Recent Clinical Trials for FLAGYL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Leiden University Medical CenterPhase 4
University of AmsterdamPhase 2
University of North Carolina, Chapel HillPhase 2

See all FLAGYL clinical trials

Pharmacology for FLAGYL

US Patents and Regulatory Information for FLAGYL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer FLAGYL metronidazole CAPSULE;ORAL 020334-001 May 3, 1995 AB RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Pfizer FLAGYL I.V. RTU IN PLASTIC CONTAINER metronidazole INJECTABLE;INJECTION 018353-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Pfizer FLAGYL ER metronidazole TABLET, EXTENDED RELEASE;ORAL 020868-001 Nov 26, 1997 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.